Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Salicylates as hypoglycemic agents.

S H Baron

    Diabetes Care
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Salicylates effectively lower blood sugar by enhancing insulin secretion, potentially through prostaglandin synthesis inhibition. Further research is needed to fully understand their hypoglycemic and hypolipidemic mechanisms in diabetes and hyperlipidemia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pejorative drift of medical words: geriatric, elitist.

    Journal of the Royal College of Physicians of London·1994
    Same author

    Possible association of interleukin-2 treatment with depression and suicide.

    The Journal of the American Osteopathic Association·1993
    Same author

    Prolactinoma in a man following industrial exposure to estrogens.

    The Western journal of medicine·1983
    Same author

    Lack of effect of acetylsalicylic acid on insulin secretion in isolated hamster Islets.

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·1982
    Same author

    Effect of prostaglandin inhibition on the prolactin, renin, and aldosterone responses to dopamine antagonism.

    Metabolism: clinical and experimental·1982
    Same author

    Zenker's diverticulum as a cause for loss of drug availability: a "new" complication.

    The American journal of gastroenterology·1982
    Same journal

    Type 1 Diabetes Driven by Residual Recipient T Cells After Hematopoietic Cell Transplantation: A Case Report.

    Diabetes care·2026
    Same journal

    Predicting the Path to Attrition: Multidomain Risk Assessment in Diabetic Foot Ulcer Offloading Randomized Controlled Trials.

    Diabetes care·2026
    Same journal

    Habituation to Elevated Glucose Levels in Type 1 Diabetes: Function and Well-Being in Guideline-Based Versus Typical Glycemic Range.

    Diabetes care·2026
    Same journal

    The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A One-Year Analysis.

    Diabetes care·2026
    Same journal

    A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

    Diabetes care·2026
    Same journal

    Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

    Diabetes care·2026
    See all related articles

    Area of Science:

    • Pharmacology and Endocrinology
    • Metabolic Diseases Research

    Background:

    • Salicylates demonstrate a glucose-lowering effect in both normal and diabetic individuals.
    • The hypoglycemic action is associated with enhanced insulin secretion, though extrapancreatic effects are possible.
    • Current understanding suggests prostaglandin synthesis inhibition mediates salicylates' impact on insulin secretion.

    Purpose of the Study:

    • To investigate the mechanism by which salicylates enhance glucose-stimulated insulin secretion.
    • To explore the effects of salicylates on insulin secretion stimulated by agents other than glucose.
    • To evaluate salicylates as potential hypoglycemic and hypolipidemic agents.

    Main Methods:

    • The study focuses on the biochemical and physiological mechanisms of salicylate action.

    Related Experiment Videos

  • Investigates the role of prostaglandin synthesis inhibition in salicylate-induced insulin secretion.
  • Examines the impact of salicylates on lipid profiles, including free fatty acids, triglycerides, and cholesterol.

    • Main Results:

    • Salicylates lower blood glucose levels and augment glucose-stimulated insulin secretion.
    • Prostaglandin synthesis inhibition is implicated as a key mechanism for enhanced insulin secretion.
    • Reported reductions in free fatty acids, triglycerides, and cholesterol levels.

    Conclusions:

    • Salicylates possess both hypoglycemic and hypolipidemic properties.
    • Understanding the precise mechanisms of salicylates can offer insights into diabetes mellitus and hyperlipidemia pathogenesis.
    • Further investigation is warranted to fully elucidate the therapeutic potential and mechanisms of salicylates.